English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Lantern Pharma (LTRN.US)$ Reuters· 2 mins ago
Lantern Pharma & Starlight Therapeutics Present LP-184 (Star-001) Phase 1B Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (Sno) 2024 Highlighting Novel Synthetic Lethality
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
9409 Views
Comment
Sign in to post a comment